Clinical Operations Lead

Stockholm / Hybrid

Medivir is a Swedish biotech company focused on developing innovative therapies for diseases with high unmet medical need. The company is currently advancing clinical programs within both oncology and rare bone diseases, including a promising liver cancer program and an upcoming Phase 2 proof-of-concept study in Osteogenesis Imperfecta (OI).

We are now looking for a hands-on, strategically minded and execution-driven Clinical Operations Lead to join our growing team.

This is a unique opportunity to become part of a lean, highly experienced, and collaborative biotech environment where you will have broad responsibility, substantial influence, and close interaction with executive leadership.

About the role
 

As Clinical Operations Lead, you will take operational ownership of an upcoming European Phase 2 study within Osteogenesis Imperfecta . The study is expected to include multiple European countries and will be conducted in close collaboration with external CROs and specialized vendors.

In parallel, you will also become involved in Medivir’s broader clinical development activities, including the company’s liver cancer program where encouraging Phase 1b/2a data has already been generated, a randomized phase 2 (IIT) is ongoing, and additional clinical development activities are planned to move forward.

The role combines operational execution with strategic involvement and offers the opportunity to contribute to future study planning and long-term clinical development as well as company strategy.

Initially, the role will have a strong operational focus, with increasing strategic involvement as the programs evolve.

Key responsibilities

• Lead operational planning and execution of clinical studies
• Act as primary sponsor contact towards CRO and external vendors
• Oversee study timelines, budgets, risks and deliverables
• Drive CRO oversight and vendor management activities
• Coordinate cross-functional collaboration across Clinical, Regulatory, Safety, Biometrics and CMC
• Support future clinical development planning and study strategy
• Contribute to operational scaling as Medivir’s pipeline progresses

We are looking for someone who

• Has experience within Clinical Operations from biotech, pharma or CRO environment
• Has worked with CRO oversight from sponsor side or in close collaboration with sponsors
• Is comfortable operating in a lean and entrepreneurial biotech environment
• Enjoys combining strategic thinking with hands-on execution
• Has a strong ownership mindset and ability to work independently
• Is detail-oriented and structured, while still able to see the bigger picture
• Thrives in collaborative and fast-moving environments

Qualifications

• Degree in Life Sciences or related field
• Several years of experience within Clinical Operations
• Understanding of ICH-GCP and global clinical trial processes
• Experience from global studies is highly meritorious
• Rare disease, oncology and/or pediatric experience is a plus, but not required

Why join Medivir?
 

At Medivir, you will become part of a highly experienced and collaborative team with deep expertise in drug development and oncology. We work closely together, value initiative and believe in giving individuals meaningful responsibility and influence.

This is an opportunity for someone who wants to:

• Take broad ownership
• Be close to strategic decision-making
• Work across both rare disease and oncology programs
• Join an entrepreneurial biotech company with exciting growth ambitions

Location

Stockholm / Hybrid

The office is currently located in Huddinge, with plans to relocate to central Stockholm.

For questions regarding the role, please contact:

Helena Marteus
helena.marteus@dedicarelifescience.com

Lisa Meijer
lisa.meijer@dedicarelifescience.com